Chinook Therapeutics (KDNY) EBITDA (2020 - 2023)
Chinook Therapeutics (KDNY) EBITDA from Dec 31, 2020 to Jun 30, 2023. The TTM Chinook Therapeutics (KDNY) EBITDA is -$247M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Chinook Therapeutics (KDNY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +204.36% |
| All Time TTM | +81.35% |
Annual EBITDA change of Chinook Therapeutics (KDNY)
| Year | EBITDA | Change |
|---|---|---|
| 2023 | -$131M | -27.31% |
| 2022 | -$180M | +77.30% |
| 2021 | -$102M | +85.20% |
| 2020 | -$55M | N/A |